Form 4: Century Therapeutics CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Century Therapeutics' CEO, Brent Pfeiffenberger, sold shares to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On February 18, 2025, Brent Pfeiffenberger, the President and CEO of Century Therapeutics, Inc. (IPSC), sold 34,712 shares of common stock at a price of $0.783 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Pfeiffenberger directly owns 1,192,545 shares of Century Therapeutics, Inc.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholders, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of stock sale transaction. |
| 02/20/2025 | Date of signature on the Form 4 filing. |
Keywords
Century Therapeutics, IPSC, Brent Pfeiffenberger, Form 4, SEC Filing, Stock Sale, Tax Obligations, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.